Clinical Trials Browser

INDUSTRY × Myeloid Malignancies × magrolimab × Clear all

NCT04778410 2025-03-20

Study of Magrolimab Combinations in Participants With Myeloid Malignancies

Phase 2 Terminated

54 enrolled 26 charts

Myeloid Malignancies